Skip to main content
Erschienen in: Journal of Neurology 1/2015

01.01.2015 | Original Communication

Frontostriatal dysexecutive syndrome: a core cognitive feature of myotonic dystrophy type 2

verfasst von: Stojan Peric, Gorana Mandic-Stojmenovic, Elka Stefanova, Dusanka Savic-Pavicevic, Jovan Pesovic, Vera Ilic, Valerija Dobricic, Ivana Basta, Dragana Lavrnic, Vidosava Rakocevic-Stojanovic

Erschienen in: Journal of Neurology | Ausgabe 1/2015

Einloggen, um Zugang zu erhalten

Abstract

The aim of this study was to assess cognitive status in a large group of patients with myotonic dystrophy type 2 (DM2) compared to type 1 (DM1) subjects matched for gender and age, using a comprehensive battery of neuropsychological tests. Thirty-four genetically confirmed adult DM2 patients were recruited and matched for gender and age with 34 adult-onset DM1 subjects. All patients underwent detailed classic pen and pencil neuropsychological investigation and also computerized automated battery—CANTAB. More than half of DM2 patients had abnormal results on executive tests [Intra/Extradimensional Set Shift (IED), Stockings of Cambridge (SOC)] and verbal episodic memory (Ray Auditory Verbal Learning Test). Regarding DM1, abnormal results in more than 50 % of subjects were achieved in even ten tests, including visuospatial, language, executive, cognitive screening and visual memory tests. Direct comparison between patient groups showed that lower percentage of DM2 patients had abnormal results on following tests: Addenbrooke’s Cognitive Examination—Revised, Raven Standard Progressive Matrices, Block Design, copy and recall of Rey-Osterieth Complex Figure, number of categories and perseverative responses on Wisconsin Card Sorting Test and Boston Naming Test (p < 0.01), as well as Trail Making Test—B and Spatial Span (p < 0.05). Our results showed significant dysexecutive syndrome and certain impairment of episodic verbal memory in DM2 patients that are reflective of frontal (especially frontostriatal) and temporal lobe dysfunction. On the other hand, dysexecutive and visuospatial/visuoconstructional deficits predominate in DM1 which correspond to the frontal, parietal (and occipital) lobe dysfunction.
Literatur
1.
Zurück zum Zitat Udd B, Krahe R (2012) The myotonic dystrophies: molecular, clinical, and therapeutic challenges. Lancet Neurol 11(10):891–905CrossRefPubMed Udd B, Krahe R (2012) The myotonic dystrophies: molecular, clinical, and therapeutic challenges. Lancet Neurol 11(10):891–905CrossRefPubMed
2.
Zurück zum Zitat de León MB, Cisneros B (2008) Myotonic dystrophy 1 in the nervous system: from the clinic to molecular mechanisms. J Neurosci Res 86(1):18–26CrossRefPubMed de León MB, Cisneros B (2008) Myotonic dystrophy 1 in the nervous system: from the clinic to molecular mechanisms. J Neurosci Res 86(1):18–26CrossRefPubMed
3.
Zurück zum Zitat Maurage CA, Udd B, Ruchoux MM, Vermersch P, Kalimo H, Krahe R, Delacourte A, Sergeant N (2005) Similar brain tau pathology in DM2/PROMM and DM1/Steinert disease. Neurology 65(10):1636–1638CrossRefPubMed Maurage CA, Udd B, Ruchoux MM, Vermersch P, Kalimo H, Krahe R, Delacourte A, Sergeant N (2005) Similar brain tau pathology in DM2/PROMM and DM1/Steinert disease. Neurology 65(10):1636–1638CrossRefPubMed
4.
Zurück zum Zitat Ono S, Inoue K, Mannen T, Mitake S, Shirai T, Kanda F, Jinnai K, Takahashi K (1989) Intracytoplasmic inclusion bodies of the thalamus and the substantia nigra, and Marinesco bodies in myotonic dystrophy: a quantitative morphological study. Acta Neuropathol 77(4):350–356CrossRefPubMed Ono S, Inoue K, Mannen T, Mitake S, Shirai T, Kanda F, Jinnai K, Takahashi K (1989) Intracytoplasmic inclusion bodies of the thalamus and the substantia nigra, and Marinesco bodies in myotonic dystrophy: a quantitative morphological study. Acta Neuropathol 77(4):350–356CrossRefPubMed
5.
Zurück zum Zitat Ono S, Takahashi K, Jinnai K, Kanda F, Fukuoka Y, Kurisaki H, Mitake S, Inagaki T, Yamano T, Nagao K (1998) Loss of serotonin-containing neurons in the raphe of patients with myotonic dystrophy: a quantitative immunohistochemical study and relation to hypersomnia. Neurology 50(2):535–538CrossRefPubMed Ono S, Takahashi K, Jinnai K, Kanda F, Fukuoka Y, Kurisaki H, Mitake S, Inagaki T, Yamano T, Nagao K (1998) Loss of serotonin-containing neurons in the raphe of patients with myotonic dystrophy: a quantitative immunohistochemical study and relation to hypersomnia. Neurology 50(2):535–538CrossRefPubMed
6.
Zurück zum Zitat Vermersch P, Sergeant N, Ruchoux MM, Hofmann-Radvanyi H, Wattez A, Petit H et al (1996) Tau variants in the brains of patients with myotonic dystrophy. Neurology 47:711–717CrossRefPubMed Vermersch P, Sergeant N, Ruchoux MM, Hofmann-Radvanyi H, Wattez A, Petit H et al (1996) Tau variants in the brains of patients with myotonic dystrophy. Neurology 47:711–717CrossRefPubMed
7.
Zurück zum Zitat Oyamada R, Hayashi M, Katoh Y, Tsuchiya K, Mizutani T, Tominaga I, Kashima H (2006) Neurofibrillary tangles and deposition of oxidative products in the brain in cases of myotonic dystrophy. Neuropathology 26(2):107–114CrossRefPubMed Oyamada R, Hayashi M, Katoh Y, Tsuchiya K, Mizutani T, Tominaga I, Kashima H (2006) Neurofibrillary tangles and deposition of oxidative products in the brain in cases of myotonic dystrophy. Neuropathology 26(2):107–114CrossRefPubMed
8.
Zurück zum Zitat Antonini G, Mainero C, Romano A, Giubilei F, Ceschin V, Gragnani F, Morino S, Fiorelli M, Soscia F, Di Pasquale A, Caramia F (2004) Cerebral atrophy in myotonic dystrophy: a voxel based morphometric study. J Neurol Neurosurg Psychiatry 75(11):1611–1613PubMedCentralCrossRefPubMed Antonini G, Mainero C, Romano A, Giubilei F, Ceschin V, Gragnani F, Morino S, Fiorelli M, Soscia F, Di Pasquale A, Caramia F (2004) Cerebral atrophy in myotonic dystrophy: a voxel based morphometric study. J Neurol Neurosurg Psychiatry 75(11):1611–1613PubMedCentralCrossRefPubMed
9.
Zurück zum Zitat Weber YG, Roebling R, Kassubek J, Hoffmann S, Rosenbohm A, Wolf M, Steinbach P, Jurkat-Rott K, Walter H, Reske SN, Lehmann-Horn F, Mottaghy FM, Lerche H (2010) Comparative analysis of brain structure, metabolism, and cognition in myotonic dystrophy 1 and 2. Neurology 74(14):1108–1117CrossRefPubMed Weber YG, Roebling R, Kassubek J, Hoffmann S, Rosenbohm A, Wolf M, Steinbach P, Jurkat-Rott K, Walter H, Reske SN, Lehmann-Horn F, Mottaghy FM, Lerche H (2010) Comparative analysis of brain structure, metabolism, and cognition in myotonic dystrophy 1 and 2. Neurology 74(14):1108–1117CrossRefPubMed
10.
Zurück zum Zitat Minnerop M, Weber B, Schoene-Bake JC, Roeske S, Mirbach S, Anspach C, Schneider-Gold C, Betz RC, Helmstaedter C, Tittgemeyer M, Klockgether T, Kornblum C (2011) The brain in myotonic dystrophy 1 and 2: evidence for a predominant white matter disease. Brain 134(12):3530–3546CrossRefPubMed Minnerop M, Weber B, Schoene-Bake JC, Roeske S, Mirbach S, Anspach C, Schneider-Gold C, Betz RC, Helmstaedter C, Tittgemeyer M, Klockgether T, Kornblum C (2011) The brain in myotonic dystrophy 1 and 2: evidence for a predominant white matter disease. Brain 134(12):3530–3546CrossRefPubMed
11.
Zurück zum Zitat Kornblum C, Reul J, Kress W, Grothe C, Amanatidis N, Klockgether T, Schröder R (2004) Cranial magnetic resonance imaging in genetically proven myotonic dystrophy type 1 and 2. J Neurol 251(6):710–714CrossRefPubMed Kornblum C, Reul J, Kress W, Grothe C, Amanatidis N, Klockgether T, Schröder R (2004) Cranial magnetic resonance imaging in genetically proven myotonic dystrophy type 1 and 2. J Neurol 251(6):710–714CrossRefPubMed
12.
Zurück zum Zitat Romeo V, Pegoraro E, Ferrati C, Squarzanti F, Sorarù G, Palmieri A, Zucchetta P, Antunovic L, Bonifazi E, Novelli G, Trevisan CP, Ermani M, Manara R, Angelini C (2010) Brain involvement in myotonic dystrophies: neuroimaging and neuropsychological comparative study in DM1 and DM2. J Neurol 257(8):1246–1255CrossRefPubMed Romeo V, Pegoraro E, Ferrati C, Squarzanti F, Sorarù G, Palmieri A, Zucchetta P, Antunovic L, Bonifazi E, Novelli G, Trevisan CP, Ermani M, Manara R, Angelini C (2010) Brain involvement in myotonic dystrophies: neuroimaging and neuropsychological comparative study in DM1 and DM2. J Neurol 257(8):1246–1255CrossRefPubMed
13.
Zurück zum Zitat Fukuda H, Horiguchi J, Ono C, Ohshita T, Takaba J, Ito K (2005) Diffusion tensor imaging of cerebral white matter in patients with myotonic dystrophy. Acta Radiol 46(1):104–109CrossRefPubMed Fukuda H, Horiguchi J, Ono C, Ohshita T, Takaba J, Ito K (2005) Diffusion tensor imaging of cerebral white matter in patients with myotonic dystrophy. Acta Radiol 46(1):104–109CrossRefPubMed
14.
Zurück zum Zitat Kassubek J, Juengling FD, Hoffmann S, Rosenbohm A, Kurt A, Jurkat-Rott K, Steinbach P, Wolf M, Ludolph AC, Lehmann-Horn F, Lerche H, Weber YG (2003) Quantification of brain atrophy in patients with myotonic dystrophy and proximal myotonic myopathy: a controlled 3-dimensional magnetic resonance imaging study. Neurosci Lett 348(2):73–76CrossRefPubMed Kassubek J, Juengling FD, Hoffmann S, Rosenbohm A, Kurt A, Jurkat-Rott K, Steinbach P, Wolf M, Ludolph AC, Lehmann-Horn F, Lerche H, Weber YG (2003) Quantification of brain atrophy in patients with myotonic dystrophy and proximal myotonic myopathy: a controlled 3-dimensional magnetic resonance imaging study. Neurosci Lett 348(2):73–76CrossRefPubMed
15.
Zurück zum Zitat Minnerop M, Luders E, Specht K, Ruhlmann J, Schneider-Gold C, Schröder R, Thompson PM, Toga AW, Klockgether T, Kornblum C (2008) Grey and white matter loss along cerebral midline structures in myotonic dystrophy type 2. J Neurol 255(12):1904–1909PubMedCentralCrossRefPubMed Minnerop M, Luders E, Specht K, Ruhlmann J, Schneider-Gold C, Schröder R, Thompson PM, Toga AW, Klockgether T, Kornblum C (2008) Grey and white matter loss along cerebral midline structures in myotonic dystrophy type 2. J Neurol 255(12):1904–1909PubMedCentralCrossRefPubMed
16.
Zurück zum Zitat Franc DT, Muetzel RL, Robinson PR, Rodriguez CP, Dalton JC, Naughton CE, Mueller BA, Wozniak JR, Lim KO, Day JW (2012) Cerebral and muscle MRI abnormalities in myotonic dystrophy. Neuromuscul Disord 22(6):483–491PubMedCentralCrossRefPubMed Franc DT, Muetzel RL, Robinson PR, Rodriguez CP, Dalton JC, Naughton CE, Mueller BA, Wozniak JR, Lim KO, Day JW (2012) Cerebral and muscle MRI abnormalities in myotonic dystrophy. Neuromuscul Disord 22(6):483–491PubMedCentralCrossRefPubMed
17.
Zurück zum Zitat Meola G, Sansone V, Perani D, Colleluori A, Cappa S, Cotelli M, Fazio F, Thornton CA, Moxley RT (1999) Reduced cerebral blood flow and impaired visual-spatial function in proximal myotonic myopathy. Neurology 53(5):1042–1050CrossRefPubMed Meola G, Sansone V, Perani D, Colleluori A, Cappa S, Cotelli M, Fazio F, Thornton CA, Moxley RT (1999) Reduced cerebral blood flow and impaired visual-spatial function in proximal myotonic myopathy. Neurology 53(5):1042–1050CrossRefPubMed
18.
Zurück zum Zitat Chang L, Anderson T, Migneco OA, Boone K, Mehringer CM, Villanueva-Meyer J, Berman N, Mena I (1993) Cerebral abnormalities in myotonic dystrophy. Cerebral blood flow, magnetic resonance imaging, and neuropsychological tests. Arch Neurol 50(9):917–923CrossRefPubMed Chang L, Anderson T, Migneco OA, Boone K, Mehringer CM, Villanueva-Meyer J, Berman N, Mena I (1993) Cerebral abnormalities in myotonic dystrophy. Cerebral blood flow, magnetic resonance imaging, and neuropsychological tests. Arch Neurol 50(9):917–923CrossRefPubMed
19.
Zurück zum Zitat Meola G, Sansone V, Perani D, Scarone S, Cappa S, Dragoni C, Cattaneo E, Cotelli M, Gobbo C, Fazio F, Siciliano G, Mancuso M, Vitelli E, Zhang S, Krahe R, Moxley RT (2003) Executive dysfunction and avoidant personality trait in myotonic dystrophy type 1 (DM-1) and in proximal myotonic myopathy (PROMM/DM-2). Neuromuscul Disord 13(10):813–821CrossRefPubMed Meola G, Sansone V, Perani D, Scarone S, Cappa S, Dragoni C, Cattaneo E, Cotelli M, Gobbo C, Fazio F, Siciliano G, Mancuso M, Vitelli E, Zhang S, Krahe R, Moxley RT (2003) Executive dysfunction and avoidant personality trait in myotonic dystrophy type 1 (DM-1) and in proximal myotonic myopathy (PROMM/DM-2). Neuromuscul Disord 13(10):813–821CrossRefPubMed
20.
Zurück zum Zitat Gaul C, Schmidt T, Windisch G, Wieser T, Müller T, Vielhaber S, Zierz S, Leplow B (2006) Subtle cognitive dysfunction in adult onset myotonic dystrophy type 1 (DM1) and type 2 (DM2). Neurology 67(2):350–352CrossRefPubMed Gaul C, Schmidt T, Windisch G, Wieser T, Müller T, Vielhaber S, Zierz S, Leplow B (2006) Subtle cognitive dysfunction in adult onset myotonic dystrophy type 1 (DM1) and type 2 (DM2). Neurology 67(2):350–352CrossRefPubMed
21.
Zurück zum Zitat Modoni A, Silvestri G, Pomponi MG, Mangiola F, Tonali PA, Marra C (2004) Characterization of the pattern of cognitive impairment in myotonic dystrophy type 1. Arch Neurol 61:1943–1947CrossRefPubMed Modoni A, Silvestri G, Pomponi MG, Mangiola F, Tonali PA, Marra C (2004) Characterization of the pattern of cognitive impairment in myotonic dystrophy type 1. Arch Neurol 61:1943–1947CrossRefPubMed
22.
Zurück zum Zitat Winblad S, Lindberg C, Hansen S (2006) Cognitive deficits and CTG repeat expansion size in classical myotonic dystrophy type 1 (DM1). Behav Brain Funct 2:16PubMedCentralCrossRefPubMed Winblad S, Lindberg C, Hansen S (2006) Cognitive deficits and CTG repeat expansion size in classical myotonic dystrophy type 1 (DM1). Behav Brain Funct 2:16PubMedCentralCrossRefPubMed
23.
Zurück zum Zitat Sansone V, Gandossini S, Cotelli M, Calabria M, Zanetti O, Meola G (2007) Cognitive impairment in adult myotonic dystrophies: a longitudinal study. Neurol Sci 28(1):9–15CrossRefPubMed Sansone V, Gandossini S, Cotelli M, Calabria M, Zanetti O, Meola G (2007) Cognitive impairment in adult myotonic dystrophies: a longitudinal study. Neurol Sci 28(1):9–15CrossRefPubMed
24.
Zurück zum Zitat Kamsteeg EJ, Kress W, Catalli C, Hertz JM, Witsch-Baumgartner M, Buckley MF, van Engelen BG, Schwartz M, Scheffer H (2012) Best practice guidelines and recommendations on the molecular diagnosis of myotonic dystrophy types 1 and 2. Eur J Hum Genet 20(12):1203–1208PubMedCentralCrossRefPubMed Kamsteeg EJ, Kress W, Catalli C, Hertz JM, Witsch-Baumgartner M, Buckley MF, van Engelen BG, Schwartz M, Scheffer H (2012) Best practice guidelines and recommendations on the molecular diagnosis of myotonic dystrophy types 1 and 2. Eur J Hum Genet 20(12):1203–1208PubMedCentralCrossRefPubMed
25.
Zurück zum Zitat Mathieu J, Boivin H, Meunier D, Gaudreault M, Begin P (2001) Assessment of a disease-specific muscular impairment rating scale in myotonic dystrophy. Neurology 56:336–340CrossRefPubMed Mathieu J, Boivin H, Meunier D, Gaudreault M, Begin P (2001) Assessment of a disease-specific muscular impairment rating scale in myotonic dystrophy. Neurology 56:336–340CrossRefPubMed
26.
Zurück zum Zitat Sahakian BJ, Owen AM (1992) Computerized assessment in neuropsychiatry using CANTAB: discussion paper. J R Soc Med 85(7):399–402PubMedCentralPubMed Sahakian BJ, Owen AM (1992) Computerized assessment in neuropsychiatry using CANTAB: discussion paper. J R Soc Med 85(7):399–402PubMedCentralPubMed
27.
Zurück zum Zitat Mioshi E, Dawson K, Mitchell J, Arnold R, Hodges JR (2006) The Addenbrooke’s Cognitive Examination Revised (ACE-R): a brief cognitive test battery for dementia screening. Int J Geriatr Psychiatry 21:1078–1085CrossRefPubMed Mioshi E, Dawson K, Mitchell J, Arnold R, Hodges JR (2006) The Addenbrooke’s Cognitive Examination Revised (ACE-R): a brief cognitive test battery for dementia screening. Int J Geriatr Psychiatry 21:1078–1085CrossRefPubMed
28.
Zurück zum Zitat Burke H (1985) Raven Progressive Matrices: more on norms, reliability, and validity. J Clin Psychol 41:231–235CrossRef Burke H (1985) Raven Progressive Matrices: more on norms, reliability, and validity. J Clin Psychol 41:231–235CrossRef
29.
Zurück zum Zitat Pavlovic D (2003) Dijagnosticki testovi u neuropsihologiji, II edn. Grafos, Beograd Pavlovic D (2003) Dijagnosticki testovi u neuropsihologiji, II edn. Grafos, Beograd
30.
Zurück zum Zitat Geffen G, Hoar KJ, O’Hanlon AP, Clark CR, Geffen LB (1990) Performance measures of 16- to 86-year-old males and females on the Auditory Verbal Learning Test. Clin Neuropsychol 4:45–63CrossRef Geffen G, Hoar KJ, O’Hanlon AP, Clark CR, Geffen LB (1990) Performance measures of 16- to 86-year-old males and females on the Auditory Verbal Learning Test. Clin Neuropsychol 4:45–63CrossRef
31.
Zurück zum Zitat Spreen O, Strauss E (1991) A compendium of neuropsychological tests. Administration, norms and commentary, Oxford University Press, New York Spreen O, Strauss E (1991) A compendium of neuropsychological tests. Administration, norms and commentary, Oxford University Press, New York
32.
Zurück zum Zitat Goodglass H, Kaplan E (1983) The assessment of aphasia and related disorders. Lea and Febiger, Philadelphia Goodglass H, Kaplan E (1983) The assessment of aphasia and related disorders. Lea and Febiger, Philadelphia
33.
Zurück zum Zitat Meola G, Sansone V (2007) Cerebral involvement in myotonic dystrophies. Muscle Nerve 36:294–306CrossRefPubMed Meola G, Sansone V (2007) Cerebral involvement in myotonic dystrophies. Muscle Nerve 36:294–306CrossRefPubMed
35.
Zurück zum Zitat Chu K, Cho JW, Song EC, Jeon BS (2002) A patient with proximal myotonic myopathy and parkinsonism. Can J Neurol Sci 29(2):188–190PubMed Chu K, Cho JW, Song EC, Jeon BS (2002) A patient with proximal myotonic myopathy and parkinsonism. Can J Neurol Sci 29(2):188–190PubMed
36.
Zurück zum Zitat Sansone V, Meola G, Perani D, Fazio F, Garibotto V, Cotelli M, Cotelli M, Vitelli E (2006) Glucose metabolism and dopamine PET correlates in a patient with myotonic dystrophy type 2 and parkinsonism. J Neurol Neurosurg Psychiatry 77(3):425–426PubMedCentralCrossRefPubMed Sansone V, Meola G, Perani D, Fazio F, Garibotto V, Cotelli M, Cotelli M, Vitelli E (2006) Glucose metabolism and dopamine PET correlates in a patient with myotonic dystrophy type 2 and parkinsonism. J Neurol Neurosurg Psychiatry 77(3):425–426PubMedCentralCrossRefPubMed
37.
Zurück zum Zitat Annic A, Devos D, Destée A, Defebvre L, Lacour A, Hurtevent JF, Stojkovic T (2008) Early dopasensitive Parkinsonism related to myotonic dystrophy type 2. Mov Disord 23(14):2100–2101PubMed Annic A, Devos D, Destée A, Defebvre L, Lacour A, Hurtevent JF, Stojkovic T (2008) Early dopasensitive Parkinsonism related to myotonic dystrophy type 2. Mov Disord 23(14):2100–2101PubMed
38.
Zurück zum Zitat Lim SY, Wadia P, Wenning GK, Lang AE (2009) Clinically probable multiple system atrophy with predominant parkinsonism associated with myotonic dystrophy type 2. Mov Disord 24(9):1407–1409CrossRefPubMed Lim SY, Wadia P, Wenning GK, Lang AE (2009) Clinically probable multiple system atrophy with predominant parkinsonism associated with myotonic dystrophy type 2. Mov Disord 24(9):1407–1409CrossRefPubMed
39.
Zurück zum Zitat Bugiardini E (2014) Meola G; DM-CNS Group. Consensus on cerebral involvement in myotonic dystrophy: workshop report: May 24-27, 2013, Ferrere (AT), Italy. Neuromuscul Disord 24(5):445–452CrossRefPubMed Bugiardini E (2014) Meola G; DM-CNS Group. Consensus on cerebral involvement in myotonic dystrophy: workshop report: May 24-27, 2013, Ferrere (AT), Italy. Neuromuscul Disord 24(5):445–452CrossRefPubMed
40.
Zurück zum Zitat Antonini G, Soscia F, Giubilei F, De Carolis A, Gragnani F, Morino S, Ruberto A, Tatarelli R (2006) Health-related quality of life in myotonic dystrophy type 1 and its relationship with cognitive and emotional functioning. J Rehabil Med 38(3):181–185CrossRefPubMed Antonini G, Soscia F, Giubilei F, De Carolis A, Gragnani F, Morino S, Ruberto A, Tatarelli R (2006) Health-related quality of life in myotonic dystrophy type 1 and its relationship with cognitive and emotional functioning. J Rehabil Med 38(3):181–185CrossRefPubMed
41.
Zurück zum Zitat Rakocevic-Stojanovic V, Peric S, Madzarevic R, Dobricic V, Ralic V, Ilic V, Basta I, Nikolic A, Stefanova E (2014) Significant impact of behavioral and cognitive impairment on quality of life in patients with myotonic dystrophy type 1. Clin Neurol Neurosurg 126C:76–81CrossRef Rakocevic-Stojanovic V, Peric S, Madzarevic R, Dobricic V, Ralic V, Ilic V, Basta I, Nikolic A, Stefanova E (2014) Significant impact of behavioral and cognitive impairment on quality of life in patients with myotonic dystrophy type 1. Clin Neurol Neurosurg 126C:76–81CrossRef
Metadaten
Titel
Frontostriatal dysexecutive syndrome: a core cognitive feature of myotonic dystrophy type 2
verfasst von
Stojan Peric
Gorana Mandic-Stojmenovic
Elka Stefanova
Dusanka Savic-Pavicevic
Jovan Pesovic
Vera Ilic
Valerija Dobricic
Ivana Basta
Dragana Lavrnic
Vidosava Rakocevic-Stojanovic
Publikationsdatum
01.01.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Neurology / Ausgabe 1/2015
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-014-7545-y

Weitere Artikel der Ausgabe 1/2015

Journal of Neurology 1/2015 Zur Ausgabe

Pioneers in Neurology

Wilhelm Uhthoff (1853–1927)

Pioneers in Neurology

Karl Stern (1906–1975)

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.